Yep great post @hottod (as usual). I think the key difference...

Yep great post @hottod (as usual).

I think the key difference between OPT and NEU is that Neuren are already starting with a decent warchest and a steady stream of income.

Also the way I read the "tea leaves" currently is that if - and thats IF - Neuren choose to go to P3 alone it seems they are only doing this for PMS only at this stage.

Ttherefore - assuming the above - I feel the dilution/investment that Neuren would need to see this alone would be another circa $300m-ish....guessing....maybe....which I would expect (IMO - guesstimate !!) they could raise under their 15% placement rule assuming they have good P2 announcements and SP appreciation.

Summarising - if ive guestimated the above correctly - I feel we will know very soon post the P2 results whether Neuren will partner up for P3 PMS, go it alone or nothing.

If its nothing, IMO this also indicates to me they are looking for either a T/O or being bought...as it wouldnt make commercial sense to take advantage of the news.

Thats my musings for the day.